Literature DB >> 7234861

Interaction between discrete causes.

J S Koopman.   

Abstract

The interaction contrast of disease rates (ICDR), a measure of deviation from an additive model of no interaction, is shown always to be zero or slightly negative when the assumptions of no interaction in the sufficient-component discrete causes model hold. Since all physical sources of interaction which one might postulate between discrete causes imply a deviation from this model, the ICDR is a good parameter to screen for causal interaction. Specific models which deviate from the assumptions of no interaction in the sufficient-component discrete causes model should be sought when the ICDR differs from zero. An example of parameterizing interaction in one such model is presented. The additive model is inconsistent with the multiplicative when two causes are studied; negative or no interaction in the multiplicative model might represent positive interaction in the additive model. Use of the multiplicative model to screen for causal interactions could thus lead to inappropriate decisions regarding the need to seek causal explanations for interaction. Since positive interaction in the multiplicative model implies positive interaction in the additive, there will be no such inappropriate decisions when positive interaction is observed in the multiplicative model.

Mesh:

Substances:

Year:  1981        PMID: 7234861     DOI: 10.1093/oxfordjournals.aje.a113153

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  The right answer for the wrong question: consequences of type III error for public health research.

Authors:  S Schwartz; K M Carpenter
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

2.  From counterfactuals to sufficient component causes and vice versa.

Authors:  Tyler J VanderWeele; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Personality, stress, smoking, and genetic predisposition as synergistic risk factors for cancer and coronary heart disease.

Authors:  H J Eysenck; R Grossarth-Maticek; B Everitt
Journal:  Integr Physiol Behav Sci       Date:  1991 Oct-Dec

4.  A competing risks approach to "biologic" interaction.

Authors:  Per Kragh Andersen; Anders Skrondal
Journal:  Lifetime Data Anal       Date:  2015-01-23       Impact factor: 1.588

5.  Epidemiology and causation: a realist view.

Authors:  A Renton
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

6.  Multiply robust inference for statistical interactions.

Authors:  Stijn Vansteelandt; Tyler J Vanderweele; James M Robins
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

7.  GENERAL THEORY FOR INTERACTIONS IN SUFFICIENT CAUSE MODELS WITH DICHOTOMOUS EXPOSURES.

Authors:  Tyler J VanderWeele; Thomas S Richardson
Journal:  Ann Stat       Date:  2012       Impact factor: 4.028

8.  Semiparametric tests for sufficient cause interaction.

Authors:  Stijn Vansteelandt; Tyler J VanderWeele; James M Robins
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2012-03       Impact factor: 4.488

9.  A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors.

Authors:  Jian Gong; Carolyn Hutter; John A Baron; Sonja Berndt; Bette Caan; Peter T Campbell; Graham Casey; Andrew T Chan; Michelle Cotterchio; Charles S Fuchs; Steven Gallinger; Edward Giovannucci; Tabitha Harrison; Richard Hayes; Li Hsu; Shuo Jiao; Yi Lin; Noralane M Lindor; Polly Newcomb; Bethann Pflugeisen; Amanda I Phipps; Thomas Rohan; Robert Schoen; Daniela Seminara; Martha L Slattery; Deanna Stelling; Fridtjof Thomas; Greg Warnick; Emily White; John Potter; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-20       Impact factor: 4.254

10.  Double jeopardy: interaction effects of marital and poverty status on the risk of mortality.

Authors:  K R Smith; N J Waitzman
Journal:  Demography       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.